EAPHARMA Trademark

Trademark Overview


On Friday, January 19, 2024, a trademark application was filed for EAPHARMA with the United States Patent and Trademark Office. The USPTO has given the EAPHARMA trademark a serial number of 98365237. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, November 19, 2024. This trademark is owned by EA Pharma Co., Ltd.. The EAPHARMA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, inflammatory, namely except inflammatory bronchial disease, metabolic, neurodegenerative, neurological, psychiatric, oncological, and viral diseases and disorders; Pharmaceutical preparations for the treatment of liver diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; Reagent paper for medical purposes

Medical information; Providing health care information via a global computer network

Pharmaceutical research and development, namely, pharmaceutical testing, inspection and research

General Information


Serial Number98365237
Word MarkEAPHARMA
Filing DateFriday, January 19, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a broken circle, inside of which are intersecting curved vertical and horizontal lines over the letters EAPharma.
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, inflammatory, namely except inflammatory bronchial disease, metabolic, neurodegenerative, neurological, psychiatric, oncological, and viral diseases and disorders; Pharmaceutical preparations for the treatment of liver diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain, and diabetes; Reagent paper for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical information; Providing health care information via a global computer network
Goods and ServicesPharmaceutical research and development, namely, pharmaceutical testing, inspection and research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEA Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 104-0042
JP

Trademark Events


Event DateEvent Description
Friday, January 19, 2024NEW APPLICATION ENTERED
Saturday, June 15, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, June 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 14, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2024ASSIGNED TO EXAMINER
Friday, October 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 19, 2024SUSPENSION LETTER WRITTEN
Tuesday, November 19, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 19, 2024LETTER OF SUSPENSION E-MAILED